Back
Grupo Financiero Inbursa SAB de CV Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
67
GPFOF
Grupo Financiero Inbursa SAB de CV
Last Price:
$2.4570
Seasonality Move:
21.86%
Sell
37
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Buy
67
Grupo Financiero Inbursa SAB de CV (GPFOF)
is a Buy
Is Grupo Financiero Inbursa SAB de CV a Buy, Sell or Hold?
-
The current Grupo Financiero Inbursa SAB de CV [GPFOF] share price is $2.4570. The Score for GPFOF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
GPFOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $37.39. The Score for DRUG is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GPFOF Stock Price Chart
What is Grupo Financiero Inbursa SAB de CV's stock price today?
-
The Grupo Financiero Inbursa SAB de CV share price today is $2.4570Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPFOF is experiencing slight buying pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $37.39The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPFOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.08 | Buy |
Relative Strength Index (14 RSI): | 82.63 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.0702 - 2.3902) | Buy |
Bollinger Bands (100): | (2.1155 - 2.3755) | Buy |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.52 | Sell |
Relative Strength Index (14 RSI): | 49.78 | Sell |
Chaikin Money Flow: | 27952 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.12 - 42.26) | Buy |
Bollinger Bands (100): | (24.86 - 48.56) | Buy |
GPFOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.44 | Buy |
20-day SMA: | 2.26 | Buy |
50-day SMA: | 2.25 | Buy |
200-day SMA: | 2.35 | Buy |
8-day EMA: | 2.42 | Buy |
20-day EMA: | 2.32 | Buy |
50-day EMA: | 2.26 | Buy |
200-day EMA: | 2.33 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.75 | Buy |
20-day SMA: | 38.76 | Sell |
50-day SMA: | 37.71 | Sell |
200-day SMA: | 18.92 | Buy |
8-day EMA: | 36.45 | Buy |
20-day EMA: | 37.51 | Sell |
50-day EMA: | 37.11 | Buy |
200-day EMA: | 24.13 | Buy |
Grupo Financiero Inbursa SAB de CV Earnings Growth & GPFOF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Grupo Financiero Inbursa SAB de CV Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |